Ropes Wealth Advisors’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-47
Closed -$1K 569
2020
Q1
$1K Sell
47
-15
-24% -$448 ﹤0.01% 514
2019
Q4
$2K Hold
62
﹤0.01% 517
2019
Q3
$2K Hold
62
﹤0.01% 531
2019
Q2
$3K Hold
62
﹤0.01% 533
2019
Q1
$3K Hold
62
﹤0.01% 495
2018
Q4
$3K Sell
62
-253
-80% -$13.3K ﹤0.01% 473
2018
Q3
$22K Hold
315
0.01% 394
2018
Q2
$18K Hold
315
﹤0.01% 425
2018
Q1
$15K Hold
315
﹤0.01% 426
2017
Q4
$15K Sell
315
-18
-5% -$827 ﹤0.01% 480
2017
Q3
$15K Hold
333
﹤0.01% 452
2017
Q2
$13K Hold
333
﹤0.01% 441
2017
Q1
$13K Sell
333
-475
-59% -$18.5K ﹤0.01% 434
2016
Q4
$30K Sell
808
-25
-3% -$894 0.01% 366
2016
Q3
$29K Sell
833
-471
-36% -$16.5K 0.01% 326
2016
Q2
$42K Sell
1,304
-196
-13% -$6K 0.01% 272
2016
Q1
$43K Sell
1,500
-185
-11% -$4.93K 0.02% 225
2015
Q4
$56K Buy
1,685
+210
+14% +$6.53K 0.02% 236
2015
Q3
$42K Sell
1,475
-201
-12% -$7.01K 0.02% 268
2015
Q2
$68K Sell
1,676
-75
-4% -$3.37K 0.04% 177
2015
Q1
$86K Buy
+1,751
New +$81.1K 0.04% 167

Other funds holding AVNS

Ropes Wealth Advisors's AVNS Position: Q2 2020 in Review

Ropes Wealth Advisors sold out of Avanos Medical (AVNS) in Q2 2020, closing a stake of 47 shares — an estimated $1K sold.

Ropes Wealth Advisors first reported a position in AVNS in Q1 2015 and held it in 21 quarters. The position peaked at $86K in Q1 2015. 277 funds tracked by Wall St. Rank hold AVNS as of Q2 2020.

  • Ropes Wealth Advisors reported no remaining Avanos Medical position as of Q2 2020 after selling out during the quarter.
  • Ropes Wealth Advisors sold 47 Avanos Medical shares in Q2 2020, an estimated $1K.
  • Ropes Wealth Advisors first reported a position in Avanos Medical in Q1 2015 and held it in 21 quarters.
  • Ropes Wealth Advisors's Avanos Medical position peaked at $86K in Q1 2015.
  • 277 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2020.

Based on Ropes Wealth Advisors's 13F filing for Q2 2020, filed 20 Jul 2020.